PLEC and prostate cancer: Integrin-linked kinase (ILK) [399], plectin (PLEC) [400,401], paxillin (PXN) [402], talin 1 (TLN1) [403,404], and vinculin (VCL) [405] are other adhesome proteins that were implicated in prostate cancer and that showed biomarker potential in this cancer type (Table 2).